SCHEMBL3660239

SCHEMBL3660239

CC#CCCCCOc1cccc(NC)c1F

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.35
TDP1 Q9NUW8 1/20 0.35
SLC6A4 P31645 2/20 0.35
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
KDM4E B2RXH2 1/20 0.33
HRH1 P35367 1/20 0.33
PTPN1 P18031 1/20 0.32
APP P05067 1/20 0.32
TP53 P04637 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C9 P11712 1/20 0.31
TSHR P16473 1/20 0.31
HTR1B P28222 2/20 0.31
LMNA P02545 1/20 0.31
GRM2 Q14416 2/20 0.31
HTR1D P28221 1/20 0.31
HTR1A P08908 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3661499 0.99 L3MBTL1 (0.34) L3MBTL1TDP1SLC6A4NPC1RAB9A
SCHEMBL3664404 0.96 SMN1; SMN2 (0.34) L3MBTL1TDP1SLC6A4NPC1RAB9A
SCHEMBL3659956 0.92 APP (0.33) L3MBTL1TDP1SLC6A4HRH1APP
SCHEMBL3659801 0.88 L3MBTL1 (0.37) L3MBTL1TDP1SLC6A4HRH1PTPN1
SCHEMBL3662259 0.84 L3MBTL1 (0.36) L3MBTL1TDP1SLC6A4HRH1PTPN1
SCHEMBL3664516 0.83 EGFR (0.35) L3MBTL1TDP1SLC6A4KDM4EHRH1
SCHEMBL3664058 0.83 L3MBTL1 (0.35) L3MBTL1TDP1SLC6A4NPC1RAB9A
SCHEMBL3659751 0.83 EGFR (0.35) L3MBTL1TDP1SLC6A4KDM4EHRH1
SCHEMBL3662361 0.83 L3MBTL1 (0.35) L3MBTL1TDP1SLC6A4HRH1PTPN1
SCHEMBL3662868 0.82 APP (0.35) L3MBTL1RAB9AAPPHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100311790-A1 AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME SUMITOMO CHIEMCAL COMPANY LIMITED (JP) 2010-12-09 US disclosed
EP-2215062-A1 AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME Sumitomo Chemical Company, Limited (JP) 2010-08-11 EP disclosed
WO-2009069792-A1 AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-06-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100311790-A1 AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME ATL3, NAT1, C5 L3MBTL1 40/4885TDP1 4310/4885SLC6A4 3430/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.